Studi epidemiologici su SARS-CoV-2

Responsabile:
Daniela Ferrante 

Il progetto intende valutare le caratteristiche associate alla severità clinica e alla mortalità in coorti di pazienti affetti da COVID-19, basandosi in particolare sull’analisi di coorti di soggetti affetti da COVID-19.


L'attività si articola come segue:

  • uno studio multicentrico internazionale in pazienti oncologici;
  • una coorte di pazienti ospedalizzati.
Pubblicazioni:
  • Time-Dependent COVID-19 Mortality in Patients With Cancer: An Updated Analysis of the OnCovid Registry.

    OnCovid Study Group, et al

    Anni: 2022
    Fonte: JAMA Oncol 2022; 8: 114-122. doi: 10.1001/jamaoncol.2021.6199. PMID: 34817562
  • Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients.

    Borgogna C, et al

    Anni: 2022
    Fonte: Blood Cancer J 2022; 12: 8. doi: 10.1038/s41408-022-00608-6. PMID: 35042847
  • Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study.

    Pinato DJ, et al

    Anni: 2021
    Fonte: Lancet Oncol 2021; 22: 1669-1680. doi: 10.1016/S1470-2045(21)00573-8. Epub 2021 Nov 3. PMID: 34741822 (IF 41.316)
  • Persistence of Neutralizing Antibodies to SARS-CoV-2 in First Wave Infected Individuals at Ten Months Post-Infection: The UnIRSA Cohort Study.

    Griffante G, et al

    Anni: 2021
    Fonte: Viruses 2021; 13: 2270. doi: 10.3390/v13112270. PMID: 34835076 (IF 5.048)
  • Interaction between thrombin potential and age on early clinical outcome in patients hospitalized for COVID-19.

    Mennuni MG, et al

    Anni: 2021
    Fonte: J Thromb Thrombolysis 2021 10: 1-8. doi: 10.1007/s11239-021-02497-1. Online ahead of print. PMID: 34110529 (IF 2.300)
  • Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study.

    Pinato DJ, et al

    Anni: 2021
    Fonte: Eur J Cancer 2021; 150: 190-202. doi: 10.1016/j.ejca.2021.03.035. Online ahead of print. PMID: 33932726 (IF 9.162)
  • Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score.

    Dettorre GM, et al

    Anni: 2021
    Fonte: J Immunother Cancer 2021; 9: e002277. doi: 10.1136/jitc-2020-002277. PMID: 33753569
  • Baseline clinical characteristics and prognostic factors in hospitalized COVID-19 patients aged ? 65 years: A retrospective observational study.

    Betti M, et al

    Anni: 2021
    Fonte: PLoS One 2021; 16: e0248829. doi: 10.1371/journal.pone.0248829. eCollection 2021. PMID: 33760885 (IF 3.240)
  • COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry.

    Garrigós L, et al

    Anni: 2021
    Fonte: Ther Adv Med Oncol 2021 Nov 2; 13: 17588359211053416. doi: 10.1177/17588359211053416. eCollection 2021. PMID: 34777582 (IF 6.852)
  • Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19.

    Spinoni EG, et al

    Anni: 2021
    Fonte: Circ Arrhythm Electrophysiol 2021; 14: e009375. doi: 10.1161/CIRCEP.120.009375. Epub 2021 Feb 16. PMID: 33591815 (IF 4.393)
  • Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19.

    Bellan M, et al

    Anni: 2021
    Fonte: Dis Markers. 2021 May 13;2021:8863053. doi: 10.1155/2021/8863053. eCollection 2021. PMID: 34055104 (IF 2.738)
  • Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective.

    Soosaipillai G, et al

    Anni: 2021
    Fonte: Ther Adv Med Oncol 2021; 13: 17588359211042224. doi: 10.1177/17588359211042224. eCollection 2021. PMID: 34497669 (IF 6.852)
  • Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients.

    Bellan M, et al

    Anni: 2020
    Fonte: Sci Rep 2020; 10(1):20731. doi: 10.1038/s41598-020-77698-4. PMID: 33244144 (IF 3.998)
  • Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe.

    Pinato DJ, et al

    Anni: 2020
    Fonte: Cancers (Basel) 2020; 12: E1841. doi: 10.3390/cancers12071841. PMID: 32650523 (IF 6.126)
  • How Large Was the Mortality Increase Directly and Indirectly Caused by the COVID-19 Epidemic? An Analysis on All-Causes Mortality Data in Italy.

    Magnani C, et al

    Anni: 2020
    Fonte: Int J Environ Res Public Health 2020; 17: E3452. doi: 10.3390/ijerph17103452. PMID: 32429172 (IF 2.849)
  • Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients.

    Pinato DJ, et al

    Anni: 2020
    Fonte: Cancer Discov 2020; 10: 1465-74. doi: 10.1158/2159-8290.CD-20-0773. Online ahead of print. PMID: 32737082 (IF 29.497)
  • [Gender and age factors affecting the mortality during the COVID-19 epidemic in Italy].

    Azzolina D, et al

    Anni: 2020
    Fonte: Epidemiol Prev 2020; 44: 252-259. doi: 10.19191/EP20.5-6.S2.125. PMID: 33412817 (IF 1.071)
Articolazione:
Epidemiologia clinica
Attività:
Studio di coorte, Studio multicentrico
Ambiti epidemiologici:
Epidemiologia clinica
Patologie:
COVID-19
Scheda aggiornata a:
30 maggio 2022 18:04

Questo sito utilizza cookie tecnici, analytics e di terze parti. Proseguendo nella navigazione accetti l'utilizzo dei cookie.